These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 17574165)

  • 61. Twelve month clinical and angiographic outcome after stenting of unprotected left main coronary artery stenosis with paclitaxel-eluting stents--results of the multicentre FRIEND registry.
    Carrié D; Eltchaninoff H; Lefèvre T; Silvestri M; Levy G; Maupas E; Brunel P; Fajadet J; Le Breton H; Gilard M; Blanchard D; Glatt B;
    EuroIntervention; 2009 Jan; 4(4):449-56. PubMed ID: 19284066
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Percutaneous coronary intervention versus coronary artery bypass graft surgery for the treatment of unprotected left main coronary artery stenosis: in-hospital and one year outcome after emergent and elective treatments.
    Hsu JT; Chu CM; Chang ST; Kao CL; Chung CM
    Int Heart J; 2008 May; 49(3):355-70. PubMed ID: 18612192
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Initial clinical impact of drug eluting stents on coronary artery bypass graft surgery.
    Kanemitsu S; Tanaka K; Tanaka J; Suzuki H; Kinoshita T
    Interact Cardiovasc Thorac Surg; 2007 Oct; 6(5):632-5. PubMed ID: 17670720
    [TBL] [Abstract][Full Text] [Related]  

  • 64. 3-year clinical outcome of patients with chronic total occlusion treated with drug-eluting stents.
    De Felice F; Fiorilli R; Parma A; Nazzaro M; Musto C; Sbraga F; Caferri G; Violini R
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1260-5. PubMed ID: 20129553
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Outcomes of nonagenarians who undergo percutaneous coronary intervention with drug-eluting stents.
    Lee MS; Zimmer R; Pessegueiro A; Jurewitz D; Tobis J
    Catheter Cardiovasc Interv; 2008 Mar; 71(4):526-30. PubMed ID: 18307230
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Outcomes and complications with off-label use of drug-eluting stents: results from the STENT (Strategic Transcatheter Evaluation of New Therapies) group.
    Brodie BR; Stuckey T; Downey W; Humphrey A; Bradshaw B; Metzger C; Hermiller J; Krainin F; Juk S; Cheek B; Duffy P; Smith H; Edmunds J; Varanasi J; Simonton CA;
    JACC Cardiovasc Interv; 2008 Aug; 1(4):405-14. PubMed ID: 19463338
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Safety and efficacy of drug-eluting balloons in percutaneous treatment of bifurcation lesions: the DEBIUT (drug-eluting balloon in bifurcation Utrecht) registry.
    Fanggiday JC; Stella PR; Guyomi SH; Doevendans PA
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):629-35. PubMed ID: 18360855
    [TBL] [Abstract][Full Text] [Related]  

  • 68. One-year outcome of patients with diabetes mellitus after percutaneous coronary intervention with three different revascularization strategies: results from the Diabetic Argentina Registry (DEAR).
    Mieres J; Fernandez-Pereira C; Risau G; Solorzano L; Pauletto R; Rodriguez-Granillo AM; Rubilar B; Stella P; Rodriguez AE
    Cardiovasc Revasc Med; 2012; 13(5):265-71. PubMed ID: 22796496
    [TBL] [Abstract][Full Text] [Related]  

  • 69. First generation versus new generation drug-eluting stents for the treatment of ostial/midshaft lesions in unprotected left main coronary artery: the Milan and New-Tokyo (MITO) registry.
    Naganuma T; Chieffo A; Takagi K; Panoulas VF; Mitomo S; Sticchi A; Latib A; Miyazaki T; Sato K; Costopoulos C; Fujino Y; Montorfano M; Carlino M; Nakamura S; Colombo A
    Catheter Cardiovasc Interv; 2015 Feb; 85(3):E63-9. PubMed ID: 25099758
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clinical results of unprotected left main coronary stenting.
    Ben-Dor I; Vaknin-Assa H; Lev E; Brosh D; Fuchs S; Assali A; Kornowski R
    Isr Med Assoc J; 2009 Mar; 11(3):154-9. PubMed ID: 19544705
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Percutaneous coronary intervention as an alternative to bypass surgery for unprotected LMCA stenosis.
    Park SJ; Kim YH
    Expert Rev Cardiovasc Ther; 2008 Sep; 6(8):1107-14. PubMed ID: 18793113
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Long-term outcomes after management of restenosis or thrombosis of drug-eluting stents.
    Mishkel GJ; Moore AL; Markwell S; Shelton MC; Shelton ME
    J Am Coll Cardiol; 2007 Jan; 49(2):181-4. PubMed ID: 17222728
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Transition from bare metal to drug eluting stenting in contemporary US practice: effect on incidence and predictors of clinically driven target lesion revascularization.
    Jonas M; Resnic FS; Levin AD; Arora N; Rogers CD
    Catheter Cardiovasc Interv; 2007 Aug; 70(2):175-83. PubMed ID: 17630659
    [TBL] [Abstract][Full Text] [Related]  

  • 74. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Angioplasty of unprotected left main coronary stenosis: Real world experience of a single-operator group from eastern India.
    Ray S; Mazumder A; Kumar S; Bhattacharjee P; Rozario D; Bandyopadhyay S; Mukherjee SS; Deb PK; Bandyopadhyay A
    Indian Heart J; 2016; 68(1):28-35. PubMed ID: 26896263
    [TBL] [Abstract][Full Text] [Related]  

  • 76. One-year results of unprotected left main disease treatment with paclitaxel-eluting stents: results of a multicenter registry.
    Sanmartin M; Baz JA; Lozano I; de la Torre JM; Hernandez JM; Bordes P; Mainar V; Mauri J; Iñiguez A
    Catheter Cardiovasc Interv; 2007 Feb; 69(3):372-7. PubMed ID: 17195194
    [TBL] [Abstract][Full Text] [Related]  

  • 77. New era of left main coronary artery treatment strategy.
    Park SJ; Park DW
    Cardiovasc Interv Ther; 2012 Jan; 27(1):1-7. PubMed ID: 24122633
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinical outcomes after PCI for acute coronary syndrome in unprotected left main coronary artery disease: insights from the Swiss Acute Left Main Coronary Vessel Percutaneous Management (SALVage) study.
    Puricel S; Adorjan P; Oberhänsli M; Stauffer JC; Moschovitis A; Vogel R; Goy JJ; Müller O; Eeckhout E; Togni M; Wenaweser P; Meier B; Windecker S; Cook S
    EuroIntervention; 2011 Oct; 7(6):697-704. PubMed ID: 21986328
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Trends in outcomes after percutaneous coronary intervention for chronic total occlusions: a 25-year experience from the Mayo Clinic.
    Prasad A; Rihal CS; Lennon RJ; Wiste HJ; Singh M; Holmes DR
    J Am Coll Cardiol; 2007 Apr; 49(15):1611-1618. PubMed ID: 17433951
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Technique of left main stenting is dependent on lesion location and distal branch protection.
    Wood F; Bazemore E; Schneider JE; Jobe RL; Mann T
    Catheter Cardiovasc Interv; 2005 Aug; 65(4):499-503. PubMed ID: 15945104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.